167 related articles for article (PubMed ID: 34883306)
21. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.
Nugent B; Lewis S; O'Sullivan JM
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007904. PubMed ID: 23440820
[TBL] [Abstract][Full Text] [Related]
22. Impact of early prophylactic feeding on long term tube dependency outcomes in patients with head and neck cancer.
Brown T; Banks M; Hughes BGM; Lin C; Kenny LM; Bauer JD
Oral Oncol; 2017 Sep; 72():17-25. PubMed ID: 28797454
[TBL] [Abstract][Full Text] [Related]
23. Feeding tube use in patients with head and neck cancer.
Lewis SL; Brody R; Touger-Decker R; Parrott JS; Epstein J
Head Neck; 2014 Dec; 36(12):1789-95. PubMed ID: 24478227
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer.
Wopken K; Bijl HP; van der Schaaf A; Christianen ME; Chouvalova O; Oosting SF; van der Laan BF; Roodenburg JL; Leemans CR; Slotman BJ; Doornaert P; Steenbakkers RJ; Verdonck-de Leeuw IM; Langendijk JA
PLoS One; 2014; 9(4):e94879. PubMed ID: 24736318
[TBL] [Abstract][Full Text] [Related]
25. Comparison of prophylactic percutaneous endoscopic gastrostomy with reactive enteral nutrition in patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy: A systematic review.
Mellors K; Ye X; Van Den Brande J; Wai Ray Mak T; Brown T; Findlay M; Bauer J
Clin Nutr ESPEN; 2021 Dec; 46():87-98. PubMed ID: 34857252
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review.
McClelland S; Andrews JZ; Chaudhry H; Teckie S; Goenka A
Oral Oncol; 2018 Dec; 87():77-81. PubMed ID: 30527247
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study.
Wiggenraad RG; Flierman L; Goossens A; Brand R; Verschuur HP; Croll GA; Moser LE; Vriesendorp R
Clin Otolaryngol; 2007 Oct; 32(5):384-90. PubMed ID: 17883560
[TBL] [Abstract][Full Text] [Related]
28. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
[TBL] [Abstract][Full Text] [Related]
29. Gastrostomy vs nasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy.
Soria A; Santacruz E; Vega-Piñeiro B; Gión M; Molina J; Villamayor M; Mateo R; Riveiro J; Nattero L; Botella-Carretero JI
Nutr Hosp; 2017 Jun; 34(3):512-516. PubMed ID: 28627183
[TBL] [Abstract][Full Text] [Related]
30. Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy.
Baschnagel AM; Yadav S; Marina O; Parzuchowski A; Lanni TB; Warner JN; Parzuchowski JS; Ignatius RT; Akervall J; Chen PY; Krauss DJ
Head Neck; 2014 Aug; 36(8):1155-61. PubMed ID: 23852670
[TBL] [Abstract][Full Text] [Related]
31. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?
Mekhail TM; Adelstein DJ; Rybicki LA; Larto MA; Saxton JP; Lavertu P
Cancer; 2001 May; 91(9):1785-90. PubMed ID: 11335904
[TBL] [Abstract][Full Text] [Related]
32. Indicators for Enteral Nutrition Use and Prophylactic Percutaneous Endoscopic Gastrostomy Placement in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy.
van der Linden NC; Kok A; Leermakers-Vermeer MJ; de Roos NM; de Bree R; van Cruijsen H; Terhaard CH
Nutr Clin Pract; 2017 Apr; 32(2):225-232. PubMed ID: 28362572
[TBL] [Abstract][Full Text] [Related]
33. Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.
Karsten RT; Al-Mamgani A; Bril SI; Tjon-A-Joe S; van der Molen L; de Boer JP; Hilgers FJM; Smeele LE; van den Brekel MWM; Stuiver MM
Head Neck; 2019 Nov; 41(11):4000-4008. PubMed ID: 31472000
[TBL] [Abstract][Full Text] [Related]
34. Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Radiat Oncol; 2015 Apr; 10():93. PubMed ID: 25896830
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ;
Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376
[TBL] [Abstract][Full Text] [Related]
36. Tube feeding during treatment for head and neck cancer - Adherence and patient reported barriers.
Brown T; Banks M; Hughes BGM; Lin C; Kenny L; Bauer J
Oral Oncol; 2017 Sep; 72():140-149. PubMed ID: 28797450
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
Ou D; Levy A; Blanchard P; Nguyen F; Garberis I; Casiraghi O; Scoazec JY; Janot F; Temam S; Deutsch E; Tao Y
Oral Oncol; 2016 Aug; 59():50-57. PubMed ID: 27424182
[TBL] [Abstract][Full Text] [Related]
38. Impact of current smoking and alcohol consumption on gastrostomy duration in patients with head and neck cancer undergoing definitive chemoradiotherapy.
O'Shea R; Byrne H; Tuckett J; O'Leary G; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):463-9. PubMed ID: 25790225
[TBL] [Abstract][Full Text] [Related]
39. Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Bourhis J; Deutsch E; Daly-Schveitzer N; Tao Y
Strahlenther Onkol; 2014 Sep; 190(9):823-31. PubMed ID: 24638267
[TBL] [Abstract][Full Text] [Related]
40. Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer.
Wopken K; Bijl HP; van der Schaaf A; van der Laan HP; Chouvalova O; Steenbakkers RJ; Doornaert P; Slotman BJ; Oosting SF; Christianen ME; van der Laan BF; Roodenburg JL; Leemans CR; Verdonck-de Leeuw IM; Langendijk JA
Radiother Oncol; 2014 Oct; 113(1):95-101. PubMed ID: 25443500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
